Shimadzu Scientific Instruments have released the MALDI-8020 benchtop MALDI-TOF mass spectrometer.
bioMérieux’s VITEK® MS MALDI-TOF MS system has been cleared by the US FDA for the expanded identification of mycobacteria, Nocardia and moulds.
This is a system for pharmaceutical label-free ultra-high-throughput screening (UHTS) for primary screens of millions of compounds.
Robotic system to pick bacterial colonies and deposit them on MALDI target plates.
Becton, Dickinson and Company has announced the global distribution of a complete portfolio of products for mass spectrometry that provides high-speed and high-confidence identification of pathogens in clinical laboratories.
Analytik Jena and Bruker Daltonics develop a new ultra-high throughput screening product for biopharmaceutical labs.
Bruker’s rapifleX MALDI-ToF/ToF system has new ToF/ToF optics and smartbeam 10 kHz laser technology.
JEOL USA have introduced of the company’s first commercially available MALDI-ToF mass spectrometer, the JEOL JMS-S3000 SpiralTOF. The SpiralTOF has new ToF ion optics with an extended flight length in a compact footprint, delivering a resolving power of greater than 60,000 (FWHM) over a wide mass range of m/z 10–30,000
Bruker has announced a novel MALDI molecular imaging system based on the high performance of the solariX FTMS. The new MALDI-solariX combines the extreme analytical performance of the solariX FTMS (resolving power > 1,000,000 at m/z400 at 7.0 tesla field strength) with a robust and highly sensitive MALDI source to provide an unrivalled platform for high performance molecular imaging of small molecules (e.g. drug, metabolites, lipids) in tissue.